VDVIX
Price
$12.34
Change
-$0.06 (-0.48%)
Updated
Dec 17 closing price
VTMNX
Price
$15.96
Change
-$0.08 (-0.50%)
Updated
Dec 17 closing price
Ad is loading...

VDVIX vs VTMNX

Header iconVDVIX vs VTMNX Comparison
Open Charts VDVIX vs VTMNXBanner chart's image
Vanguard Developed Markets Index I
Price$12.34
Change-$0.06 (-0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Developed Markets Index Instl
Price$15.96
Change-$0.08 (-0.50%)
VolumeN/A
CapitalizationN/A
VDVIX vs VTMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VDVIX vs. VTMNX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VDVIX is a StrongBuy and VTMNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VDVIX (198B) and VTMNX (198B) have equal amount of cash in the bank . VTMNX (3.27) and VDVIX (3.17) have matching dividends . VDVIX was incepted earlier than VTMNX: VDVIX (11 years) vs VTMNX (24 years). VDVIX (3.00) and VTMNX (3.00) have comparable annual turnover. VDVIX has a lower initial minimum investment than VTMNX: VDVIX (0) vs VTMNX (5000000). VDVIX (6.60) and VTMNX (6.58) have marching annual gain over last year. VTMNX (15.03) and VDVIX (15.00) have equivalent 5 years return.
VDVIXVTMNXVDVIX / VTMNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD3.7373.750100%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets198B198B100%
Annual Yield % from dividends3.173.2797%
Returns for 1 year6.606.58100%
Returns for 3 years1.181.2396%
Returns for 5 years15.0015.03100%
Returns for 10 years36.3436.7199%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUBS741.67-5.24
-0.70%
HUBSPOT
LMND43.00-0.75
-1.71%
Lemonade
CVLT166.44-4.40
-2.58%
Commvault Systems
CPS14.78-0.40
-2.64%
Cooper-Standard Automotive
GDTC2.57-0.08
-3.02%
CytoMed Therapeutics Limited